Stock Information

VALBIOTIS specializes in developing innovative nutrition solutions designed to prevent cardiometabolic diseases and provide nutritional support for patients. Its products are made for manufacturers in the agro-food and pharmaceutical industries. VALBIOTIS particularly focuses on solutions to prevent type 2 diabetes, NASH (nonalcoholic steatohepatitis), obesity and cardiovascular diseases.
Valbiotis has been listed on Euronext Growth since 7 June 2017.

  • Label: Valbiotis
  • Mnemonic: ALVAL
  • ISIN code: FR 0013254851
  • PEA-PME eligible: Oui
  • Trading Market: ALTERNEXT ALLSHARE
    NEXT BIOTECH
  • Total number of shares: 3 647 072

Capital allocation

  • Institution: Portzamparc
  • Analyst: Arnaud Guérin
  • Institution: Invest Securities
  • Analysts: Martial Descoutures - Thibaut Voglimacci-Stephanopoli